Group
ADC
The data below refer to patients treated with ADC as the sole drug class,
excluding any concurrent use of drugs from other groups.
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.
Sacituzumab Govitecan
Trastuzumab Deruxtecan
Trastuzumab Emtansine
Datopotamab Deruxtecan
No data
Enfortumab Vedotin
No data
Mirvetuximab Soravtansine
No data
Telisotuzumab vedotin
No data
Tisotumab Vedotin
No data